PRIME Dry Spell Ends As EMA Takes On Eye Disease Gene Therapy

 
• By Neena Brizmohun
  
Human eye
The EMA has accepted a gene therapy for an eye disorder onto PRIME • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from Pathways & Standards